$1.02
-0.03-2.86%
Last update: 12:49 PM
15 minutes delayed
Comments
Loading...
Seres Therapeutics (NASDAQ:MCRB) Stock, Earnings Estimates, EPS, And Revenue
Seres Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Oct 31
EPS Estimate
$-0.240
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$374K
Analyze the earnings history of Seres Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Seres Therapeutics (MCRB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-13 | $-0.22 | $-0.27 | 18.5 % |
| Mar 2024 | 2024-05-08 | $-0.27 | $-0.34 | 20.6 % |
| Dec 2023 | 2024-03-05 | $-0.32 | $-0.50 | 36.0 % |
| Sep 2023 | 2023-11-02 | $-0.37 | $-0.50 | 26.0 % |
Seres Therapeutics (MCRB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $0 | $250.00K | -100.0 % |
| Sep 2023 | 2023-11-02 | $310.00K | $1.87M | -83.4 % |
| Jun 2023 | 2023-08-08 | $126.47M | $125.50M | 0.78 % |
| Mar 2023 | 2023-05-09 | $-522.00K | $1.38M | -137.8 % |
FAQ
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
Seres Therapeutics (MCRB) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
What were the latest earnings per share (EPS) for Seres Therapeutics (NASDAQ:MCRB)?
The Actual EPS was $-0.22, which beat the estimate of $-0.27.
What were Seres Therapeutics’s (NASDAQ:MCRB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.